1. 2019
  2. NGS HIGH RESOLUTION TYPING IN COMBINATION WITH PIRCHE AS A TOOL TO SELECT A PERMISSIBLE HSCT DONOR

    Christiansen, M., Verheyden, S., Schimanski, A., Niemann, M., Lauterbach, N., Melista, E., Sorensen, B. S., Moller, B. K. & Demanet, C., May 2019, In : HLA. 93, 5, p. 389-389

    Research output: Contribution to journalMeeting abstract (Journal)

  3. 2017
  4. False homozygous HLA genotyping results due to copy number neutral loss of heterozygosity in acquired aplastic anaemia

    Heyrman, B., De Becker, A., Verheyden, S. & Demanet, C., 2017, In : BMJ Case Reports. 2017, 4 p., 217867.

    Research output: Contribution to journalArticle

  5. 2016
  6. 2013
  7. Response: KIR/HLA incompatibility in HIV-1 transmission and importance of the 'missing self' model

    Jennes, W., Verheyden, S., Mertens, J. W., Camara, M., Seydi, M., Dieye, T. N., Mboup, S., Demanet, C. & Kestens, L., 12 Sep 2013, In : Blood. 122, 11, p. 1984-1985 2 p.

    Research output: Contribution to journalArticle

  8. Inhibitory KIR/HLA incompatibility between sexual partners confers protection against HIV-1 transmission.

    Jennes, W., Verheyden, S., Mertens, J. W., Camara, M., Seydi, M., Dieye, T. N., Mboup, S., Demanet, C. & Kestens, L., 14 Feb 2013, In : Blood. 121, 7, p. 1157-1164

    Research output: Contribution to journalArticle

  9. Heterosexual HIV-1 transmission is associated with allogeneic KIR/HLA ligand combinations governing natural killer cell alloreactivity

    Jennes, W., Verheyden, S., Demanet, C., Mertens, J. W., Camara, C., Seydi, M., Dieye, T., Mboup, S. & Kestens, L., 2013, p. 39. 1 p.

    Research output: Unpublished contribution to conferencePoster

  10. 2011
  11. Low CD4+ T Cell Counts among African HIV-1 Infected Subjects with Group B KIR Haplotypes in the Absence of Specific Inhibitory KIR Ligands.

    Jennes, W., Verheyden, S., Demanet, C., Menten, J., Vuylsteke, B., Nkengasong, J. & Kestens, L., 14 Feb 2011, In : PLoS ONE. 6, 2, e17043.

    Research output: Contribution to journalArticle

  12. 2008
  13. Role of the inhibitory KIR ligand HLA-Bw4 and HLA-C expression levels in the recognition of leukemic cells by Natural Killer cells.

    Verheyden, S., Ferrone, S., Mulder, A., Claas, F., Schots, H., De Moerloose, B., Benoit, Y. & Demanet, C., 8 Oct 2008, In : Cancer Immunol Immunother. 58, 2009, p. 855-865 11 p.

    Research output: Contribution to journalArticle

  14. NK cell receptors and their ligands in leukemia

    Verheyden, S. & Demanet, C., 22 Feb 2008, In : Leukemia. 22, 2008, p. 249-257 9 p.

    Research output: Contribution to journalArticle

Previous 1 2 Next

ID: 140314